Stock ENDV ENDONOVO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Endonovo Therapeutics, Inc.

Equities

ENDV

US29272H3003

Market Closed - OTC Markets
Other stock markets
 18:24:54 31/05/2024 BST 		5-day change 1st Jan Change
0.0011 USD -8.33% Intraday chart for Endonovo Therapeutics, Inc. -15.38% -87.36%
2023 Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENDONOVO THERAPEUTICS, INC. Stock Endonovo Therapeutics, Inc.
 415K - - - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. ENDV Stock
  4. Charts Endonovo Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW